Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
Tougeron D, Dahan L, Evesque L, Le Malicot K, El Hajbi F, Aparicio T, Bouché O, Bonichon Lamichhane N, Chibaudel B, Angelergues A, Bodere A, Phelip JM, Mabro M, Kaluzinski L, Petorin C, Breysacher G, Rinaldi Y, Zaanan A, Smith D, Gouttebel MC, Perret C, Etchepare N, Emile JF, Sanfourche I, Di Fiore F, Lepage C, Artru P, Louvet C; PRODIGE 59-FFCD 1707-DURIGAST Investigators/Collaborators. Tougeron D, et al. Among authors: zaanan a. JAMA Oncol. 2024 Apr 4. doi: 10.1001/jamaoncol.2024.0207. Online ahead of print. JAMA Oncol. 2024. PMID: 38573643
Colon cancer mutation: prognosis/prediction--letter.
Zaanan A, Bonnetain F, Sinicrope FA, Laurent-Puig P, Taïeb J. Zaanan A, et al. Clin Cancer Res. 2013 Mar 1;19(5):1300. doi: 10.1158/1078-0432.CCR-12-3765. Epub 2013 Feb 8. Clin Cancer Res. 2013. PMID: 23396047 No abstract available.
[Clinical and molecular consequences of microsatellite instability in human cancers].
Hamelin R, Chalastanis A, Colas C, El Bchiri J, Mercier D, Schreurs AS, Simon V, Svrcek M, Zaanan A, Borie C, Buhard O, Capel E, Zouali H, Praz F, Muleris M, Fléjou JF, Duval A. Hamelin R, et al. Among authors: zaanan a. Bull Cancer. 2008 Jan;95(1):121-32. doi: 10.1684/bdc.2008.0571. Bull Cancer. 2008. PMID: 18230578 Free article. Review. French.
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.
Zaanan A, Costes L, Gauthier M, Malka D, Locher C, Mitry E, Tougeron D, Lecomte T, Gornet JM, Sobhani I, Moulin V, Afchain P, Taïeb J, Bonnetain F, Aparicio T. Zaanan A, et al. Ann Oncol. 2010 Sep;21(9):1786-1793. doi: 10.1093/annonc/mdq038. Epub 2010 Mar 11. Ann Oncol. 2010. PMID: 20223786 Free article.
[Small bowel adenocarcinoma].
Zaanan A, Afchain P, Carrere N, Aparicio T. Zaanan A, et al. Gastroenterol Clin Biol. 2010 Aug-Sep;34(6-7):371-9. doi: 10.1016/j.gcb.2010.01.020. Epub 2010 May 27. Gastroenterol Clin Biol. 2010. PMID: 20537487 Free article. Review. French.
Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
Zaanan A, Gauthier M, Malka D, Locher C, Gornet JM, Thirot-Bidault A, Tougeron D, Taïeb J, Bonnetain F, Aparicio T; Association des Gastro Entérologues Oncologues. Zaanan A, et al. Cancer. 2011 Apr 1;117(7):1422-8. doi: 10.1002/cncr.25614. Epub 2010 Nov 8. Cancer. 2011. PMID: 21425142 Free article.
Medical treatment of pancreatic cancer: new hopes after 10 years of gemcitabine.
Trouilloud I, Dubreuil O, Boussaha T, Lepère C, Landi B, Zaanan A, Bachet JB, Taieb J. Trouilloud I, et al. Among authors: zaanan a. Clin Res Hepatol Gastroenterol. 2011 May;35(5):364-74. doi: 10.1016/j.clinre.2011.02.002. Epub 2011 Mar 23. Clin Res Hepatol Gastroenterol. 2011. PMID: 21435966 Review.
139 results